Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01439386 · ClinicalTrials.gov registry record · Phase 3
Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter
A Phase 3 study, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- Completed
- Registry status
- Phase 3
- Development phase
- 86
- Enrollment target
NCT01439386 is a Phase 3 study that has completed, run by Texas Cardiac Arrhythmia Research Foundation. The registered enrollment target is 86 participants.
The verdict
NCT01439386, a Phase 3 study, has completed, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 86 participants
- Enrollment target
Study Summary
This prospective, multi-center, single blinded study aims to compare the influence of two different catheter ablation strategies, on long-term ablation outcome in terms of AF recurrence and quality of life (QoL) in patients presenting with coexistent AF and AFL. The two strategies to be evaluated are 1) the ablation of paroxysmal atrial fibrillation (PAF) with or without flutter (AFL) ablation (AF ± AFL) versus 2) AFL ablation alone.
Interventions
- PROCEDURE Catheter ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2011-09 |
| Est. Completion | 2016-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01439386
The ClinicalTrials.gov registry entry for NCT01439386 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Cardiac Arrhythmia Research Foundation, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Catheter ablation is the first listed.
NCT01439386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01439386 about?
NCT01439386 is a clinical study titled "Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter". This prospective, multi-center, single blinded study aims to compare the influence of two different catheter ablation strategies, on long-term ablation outcome in terms of AF recurrence and quality of life (QoL) in patients presenting with coexistent AF and AFL. The two strategies to be evaluated ar...
What is the current status of trial NCT01439386?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 86 participants. The study started on 2011-09. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01439386?
The interventions under investigation include: Catheter ablation (PROCEDURE).
Who is sponsoring clinical trial NCT01439386?
This trial is sponsored by Texas Cardiac Arrhythmia Research Foundation, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.